SmithKline Phase IV commitments include Nicorette study on use by adolescents.
This article was originally published in The Tan Sheet
Executive Summary
SMITHKLINE's PHASE IV COMMITMENTS INCLUDE NICORETTE STUDY ON ADOLESCENT USE of the smoking- cessation aid. In a Feb. 12 letter, FDA reminded SmithKline Beecham of its post-marketing commitment to "conduct an appropriate study of the safety and effectiveness" of Nicorette gum use by adolescents.